Aardvark Therapeutics Inc. Common Stock (AARD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aardvark Therapeutics Inc...

    NASDAQ: AARD · Real-Time Price · USD
    16.08
    0.71 (4.62%)
    At close: Oct 03, 2025, 3:59 PM
    16.49
    2.55%
    After-hours: Oct 03, 2025, 07:58 PM EDT

    Aardvark Therapeutics Common Stock Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 16K 97K 110K
    Gross Profit
    		 -16K -97K -110K
    Operating Income
    		 -22.79M -7.42M -11.36M
    Interest Income
    		 2.41M 1.42M 120K
    Pretax Income
    		 -20.59M -7.21M -13.56M
    Net Income
    		 -20.59M -7.21M -13.56M
    Selling & General & Admin
    		 5.3M 2.17M 2.7M
    Research & Development
    		 17.36M 4.48M 7.17M
    Other Expenses
    		 117K 762K 1.49M
    Operating Expenses
    		 22.79M 7.42M 11.36M
    Interest Expense
    		 n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 22.79M 7.42M 11.36M
    Income Tax Expense
    		 n/a n/a n/a
    Shares Outstanding (Basic)
    		 12.91M 12.91M 9.73M
    Shares Outstanding (Diluted)
    		 12.91M 12.91M 9.73M
    EPS (Basic)
    		 -1.59 -0.56 -1.39
    EPS (Diluted)
    		 -1.59 -0.56 -1.39
    EBITDA
    		 -20.57M -7.32M -10.25M
    EBIT
    		 -20.59M -7.42M -10.36M
    Depreciation & Amortization
    		 16K 97K 110K

    Add to Watchlist